Alcon Now Part of Novartis--Finally

YahooFinance posted the following: "Swiss pharmaceutical company Novartis AG said Wednesday it has reached a deal with minority shareholders of Alcon Inc. to complete its $51 billion takeover of the eye care company, the largest such deal in Swiss corporate history. Novartis said the cost of acquiring the remaining minority stake in Alcon of 23 percent will be $12.9 billion -- or about $1 billion dollars more than it had originally offered."

Forbes headlines the deal: "Novartis Is Eye-Care King After Acquiring Alcon."